New Treatments in Chronic Rhinosinusitis with Nasal Polyps: Expert Insights into the Evidence

Target Audience

This activity is designed to meet the educational needs of allergists, otolaryngologists (ENTs), rhinologists, primary care/ family medicine/internal medicine physicians and advanced practice providers who diagnose and treat allergic and pulmonary diseases.

Program Overview

Chronic rhinosinusitis (CRS) is a complex inflammatory disorder, with multiple clinical phenotypes, affecting approximately 10% of adults in the United States (US). Patients with CRS with nasal polyps (CRSwNP) have a more clinically severe form of the disease, which has a substantial negative impact in health-related quality of life. The goal of this educational activity is to improve clinicians’ knowledge and competence within the educational gaps of diagnosis, management, and treatment of CRSwNP. To optimize the outcomes of patients with CRSwNP, this activity will address clinical features of the disease, its pathophysiology and immunology, strategies for longitudinal multidisciplinary management, and current and emerging therapies for optimal individualized treatment plans.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Describe clinical features and key concepts in the pathophysiology and immunology of CRSwNP.
Evaluate strategies for longitudinal management using a multidisciplinary approach.
Discuss current and emerging therapies and treatment selection based on patient inflammatory phenotype, comorbidities and other individual factors.